[Asia Economy Reporter Myung-Hwan Lee]
▲Kwanglim=Announced that it is actively considering the acquisition of Ssangyong Motor to strengthen business competitiveness and enhance corporate value. Specific details such as the selection of a preferred negotiator or contract signing will be disclosed once finalized.
▲Maeil Dairies=Disposed of 40,620 treasury shares to provide stocks to executives and employees. Disposal price per share is 67,900 KRW, with an expected disposal amount of 2,758.1 million KRW.
▲Jetema=Received approval for Phase 3 clinical trial plan to confirm efficacy and safety after administration of 100 units of MotherToxin (Clostridium botulinum toxin type A) for glabellar wrinkles.
▲Engchem Life Sciences=Voluntarily discontinued Phase 2 clinical trial of EC-18 for the treatment of neutropenia.
▲Ginaine Pharm=CEO Nam Seong-ho resigned due to personal reasons. Kim Chan-gyu appointed as new CEO.
▲CS Bearing=Decided on a rights offering followed by a general public offering of forfeited shares to raise approximately 56 billion KRW for facility funds and others.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
